Page 154 - Read Online

Chen et al. Hepatoma Res 2019;5:12 I http://dx.doi.org/10.20517/2394-5079.2019.03 Page 17 of 17

132. Shih ST, Crowley S, Sheu JC. Cost-effectiveness analysis of a two-stage screening intervention for hepatocellular carcinoma in
Taiwan. J Formos Med Assoc 2010;109:39-55.
133. Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR
imaging-a systematic review and meta-analysis. Radiology 2015;275:97-109.
134. Li Q, Liu F, Wei YG, Li B. Quality assessment of Chinese clinical practice guidelines of primary hepatic carcinoma from 2016 to
2017. Chin J Evidence-Based Med 2018;18:1109-13. (in Chinese)
135. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, et al. Pretransplantation surveillance for possible hepatocellular
carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic
correlation. Radiology 2000;217:743-9.
136. Lv GS, ChenL, Wang HY. Research progress and prospect of liver cancer in China. Chin Bull Life Sci 2015;7:237-48. (in Chinese)
137. Waidely E1, Al-Yuobi AR, Bashammakh AS, El-Shahawi MS, Leblanc RM. Serum protein biomarkers relevant to hepatocellular
carcinoma and their detection. Analyst 2016;141:36-44.
138. Anwar SL, Lehmann U. MicroRNAs: emerging novel clinical biomarkers for Hepatocellular Carcinomas. J Clin Med 2015;4:1631-50.
139. Lou J, Zhang L, Lv S, Zhang C, Jiang S. Biomarkers for Hepatocellular Carcinoma. Biomark Cancer 2017;9:1-9.
140. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers
for the early detection of hepatocellular carcinoma. Gastroenterology 2010;138:493-502.
141. Yang JD, Patel T. Early detection of hepatocellular carcinoma-expanding the utility of circulating tumor Markers. Hepatology
2019;69:1855-7.
142. Duarte-Salles T, Misra S, Stepien M, Plymoth A, Muller D, et al. Circulating osteopontin and prediction of hepatocellular carcinoma
development in a large European population. Cancer Prev Res (Phila) 2016;9:758-65.
143. Rabeneck L, Lansdorp-Vogelaar I. Assessment of a cancer screening program. Best Pract Res Clin Gastroenterol 2015;29:979-85.
144. Jung M. National cancer screening programs and evidence-based healthcare policy in South Korea. Health Policy 2015;119:26-32.
145. Beste LA, Ioannou GN, Yang Y, Chang MF, Ross D, et al. Improved surveillance for hepatocellular carcinoma with a primary care-
oriented clinical reminder. Clin Gastroenterol Hepatol 2015;13:172-9.
146. Roskilly A, Rowe IA. Surveillance for hepatocellular cancer. Clin Med (Lond) 2018;18:s66-9.
147. WHO. Screening for various cancers. Available from: https://www.who.int/cancer/detection/variouscancer/en/. [Last accessed on 6 Jan
2019]